FDA Announces Nationwide Recall of Certain Thyroid Medication Due to Excess Potency Risk

As reported on The Hill, Vitruvias Therapeutics has initiated a voluntary nationwide recall of a specific lot of thyroid medication after testing indicated the tablets may contain higher-than-labeled potency, according…

Continue Reading FDA Announces Nationwide Recall of Certain Thyroid Medication Due to Excess Potency Risk